By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure To Report Fourth Quarter, Year-End Financial Results 2/2/2016 11:15:35 AM
NovoCure Submits PMA Partial Amendment Application To Japanese Pharmaceuticals And Medical Devices Agency For Treatment Of Newly Diagnosed Glioblastoma Patients 1/8/2016 12:10:26 PM
NovoCure Files Premarket Approval Supplement Application With FDA For Second Generation Optune System 1/6/2016 11:05:11 AM
NovoCure To Participate In 34th Annual J.P. Morgan Healthcare Conference 1/4/2016 7:43:40 AM
NovoCure To Hold Webcast To Discuss JAMA Publication Of EF-14 Phase 3 Clinical Trial Data 12/15/2015 11:18:51 AM
NovoCure Release: JAMA Publishes Pivotal Phase III Data For Optune Plus Temozolomide To Treat Newly Diagnosed Glioblastoma 12/15/2015 10:38:35 AM
NovoCure To Hold Webcast To Discuss JAMA Publication Of EF-14 Phase III Clinical Trial Data 12/15/2015 10:26:42 AM
NovoCure Release: New Data On Tumor Treating Fields' Anti-Mitotic Mechanism Of Action Published In Scientific Reports 12/14/2015 1:10:28 PM
NovoCure Release: Retrospective Analysis Shows Optune Safe In Glioblastoma Patients With Implanted Non-Programmable Shunts 12/4/2015 11:11:22 AM
NovoCure Release: Preliminary Phase 2 Data Demonstrate Tumor Treating Fields Is Safe In Patients With Brain Metastases Originating From Non-Small Cell Lung Cancer 12/2/2015 1:27:21 PM